Tiziano Bernasocchi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 5 | 2021 | 2981 | 0.920 |
Why?
|
| Nuclear Proteins | 5 | 2021 | 5791 | 0.700 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2021 | 169 | 0.690 |
Why?
|
| Oncogene Proteins | 1 | 2021 | 719 | 0.550 |
Why?
|
| Prostatic Neoplasms | 4 | 2021 | 11345 | 0.360 |
Why?
|
| Receptors, Androgen | 2 | 2021 | 1077 | 0.200 |
Why?
|
| Glutathione Transferase | 1 | 2024 | 565 | 0.200 |
Why?
|
| Mutation | 4 | 2021 | 29932 | 0.190 |
Why?
|
| Immunoprecipitation | 2 | 2021 | 877 | 0.190 |
Why?
|
| Glutamine | 1 | 2023 | 576 | 0.180 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 191 | 0.180 |
Why?
|
| Mice, Nude | 2 | 2021 | 3607 | 0.140 |
Why?
|
| Carcinosarcoma | 1 | 2017 | 104 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 3084 | 0.130 |
Why?
|
| Patient Care | 1 | 2021 | 624 | 0.130 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2017 | 217 | 0.130 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2017 | 194 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1791 | 0.120 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2017 | 276 | 0.120 |
Why?
|
| Protein Conformation | 1 | 2021 | 3969 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2021 | 3446 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2021 | 5434 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4264 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3844 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2024 | 8515 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2514 | 0.090 |
Why?
|
| Protein Binding | 2 | 2021 | 9335 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2020 | 2566 | 0.090 |
Why?
|
| Alleles | 1 | 2021 | 6898 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 16939 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 11071 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2021 | 23376 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 1602 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 1894 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 1357 | 0.070 |
Why?
|
| Proteomics | 1 | 2021 | 3817 | 0.070 |
Why?
|
| Genotype | 1 | 2021 | 12960 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 5351 | 0.070 |
Why?
|
| Models, Biological | 1 | 2021 | 9467 | 0.060 |
Why?
|
| Receptor, erbB-2 | 1 | 2015 | 2554 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2015 | 4000 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2017 | 5253 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 9585 | 0.050 |
Why?
|
| Neoplasms | 2 | 2023 | 22072 | 0.050 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 2014 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2016 | 4938 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3610 | 0.050 |
Why?
|
| Glutamates | 1 | 2023 | 391 | 0.050 |
Why?
|
| Proline | 1 | 2023 | 457 | 0.050 |
Why?
|
| Algorithms | 1 | 2021 | 13981 | 0.040 |
Why?
|
| Fibronectins | 1 | 2024 | 722 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17790 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2023 | 10446 | 0.040 |
Why?
|
| Mice | 3 | 2024 | 81208 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2024 | 730 | 0.040 |
Why?
|
| Facies | 1 | 2020 | 223 | 0.040 |
Why?
|
| Animals | 5 | 2024 | 167963 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2017 | 12103 | 0.040 |
Why?
|
| Male | 5 | 2021 | 359744 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2017 | 178 | 0.030 |
Why?
|
| Acetanilides | 1 | 2017 | 169 | 0.030 |
Why?
|
| Azepines | 1 | 2017 | 330 | 0.030 |
Why?
|
| Skull | 1 | 2020 | 815 | 0.030 |
Why?
|
| Humans | 9 | 2024 | 760621 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 279 | 0.030 |
Why?
|
| Cell Survival | 1 | 2024 | 5797 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 1649 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 987 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 4902 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 1008 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 2015 | 535 | 0.030 |
Why?
|
| Triazoles | 1 | 2017 | 904 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2192 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4573 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 21025 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2015 | 1998 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 6315 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2803 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 22023 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5794 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3758 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9501 | 0.010 |
Why?
|
| Female | 4 | 2024 | 391270 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13502 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36060 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 42063 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 58741 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13630 | 0.010 |
Why?
|
| Child | 1 | 2020 | 79806 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 87810 | 0.010 |
Why?
|